Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,153 | 38,776 | 41,350 | 4,204 | 4,523 |
| Receivables | 197 | 163 | 48 | 37 | 13 |
| TOTAL | $37,863 | $39,218 | $41,582 | $4,400 | $4,578 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 93 | 108 | 126 | 87 | 9 |
| TOTAL | $93 | $108 | $126 | $87 | $9 |
| Total Assets | $37,956 | $39,325 | $41,708 | $4,486 | $4,587 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 381 | 390 | 278 | 330 | 120 |
| TOTAL | $437 | $444 | $330 | $389 | $131 |
| Non-Current Liabilities | |||||
| TOTAL | $45 | $62 | $79 | $29 | $N/A |
| Total Liabilities | $483 | $506 | $408 | $418 | $131 |
| Shareholders' Equity | |||||
| Common Shares | 65,005 | 62,603 | 63,578 | 26,033 | 25,609 |
| Retained earnings | -30,722 | -25,941 | -24,497 | -25,243 | -24,534 |
| Other shareholders' equity | 3,190 | 2,157 | 2,219 | 3,279 | 3,382 |
| TOTAL | $37,473 | $38,819 | $41,300 | $4,069 | $4,457 |
| Total Liabilities And Equity | $37,956 | $39,325 | $41,708 | $4,486 | $4,587 |